195
Views
55
CrossRef citations to date
0
Altmetric
Miscellaneous

No additional steroid‐sparing effect of cyclosporine A in giant cell arteritis

, , , &
Pages 327-329 | Received 16 Aug 2005, Accepted 04 Nov 2005, Published online: 12 Jul 2009

References

  • Weyand C. M., Goronzy J. J. Medium‐ and large‐vessel vasculitis. N Engl J Med 2003; 349: 160–9
  • Ferraccioli G. F., Di Poi E., Damato R. Steroid sparing therapeutic approaches to polymyalgia rheumatica–giant cell arteritis. State of the art and perspectives. Clin Exp Rheumatol 2000; 18((Suppl 20))58–60
  • Hoffman G. S., Cid M. C., Hellmann D. B., Guillevin L., Stone J. H., Schousboe J., et al. A multicentre, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002; 46: 1309–18
  • Jover J. A., Hernandez‐Garcia C., Morado I. C., Vargas E., , Jover J. A., Hernandez‐Garcia C., Morado I. C., Vargas E., Banares A., Fernandez‐Gutierrez B, et al. Combined treatment of giant‐cell arteritis with methotrexate and prednisone: a randomized, double‐blind, placebo‐controlled trial. Ann Intern Med 2001; 134: 106–14
  • Yocum D. Immunological actions of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993; 32((Suppl))38–41
  • Kenichirou T., Ryuichi A., Tomoki I., Michihiko M., Masashi T., Shirou F. Immunomulatory effects of cyclosporine A on human peripheral blood dendritic cell subsets. Immunology 2003; 108: 321–31
  • Schaufelberger C., Andersson R., Nordborg E. No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis. Results of an open, controlled, randomized trial. Br J Rheumatol 1998; 37: 464–5
  • Hunder G. G., Bloch D. A., Michel B. A., Stevens M. B., Arend W. P., Calabrese L. H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122–8
  • Zachariae H. Renal toxicity of long‐term cyclosporin. Scand J Rheumatol 1999; 28: 65–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.